Journey Medical Corp (DERM)
3.45
-0.17
(-4.70%)
USD |
NASDAQ |
May 17, 16:00
3.45
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Enterprise Value: 59.67M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 59.67M |
| May 16, 2024 | 63.07M |
| May 15, 2024 | 62.47M |
| May 14, 2024 | 62.87M |
| May 13, 2024 | 61.93M |
| May 10, 2024 | 60.73M |
| May 09, 2024 | 61.13M |
| May 08, 2024 | 61.93M |
| May 07, 2024 | 59.33M |
| May 06, 2024 | 61.53M |
| May 03, 2024 | 64.33M |
| May 02, 2024 | 63.13M |
| May 01, 2024 | 60.73M |
| April 30, 2024 | 64.33M |
| April 29, 2024 | 57.14M |
| April 26, 2024 | 58.53M |
| April 25, 2024 | 60.39M |
| April 24, 2024 | 58.40M |
| April 23, 2024 | 61.19M |
| April 22, 2024 | 61.19M |
| April 19, 2024 | 59.99M |
| April 18, 2024 | 61.98M |
| April 17, 2024 | 67.57M |
| April 16, 2024 | 66.37M |
| April 15, 2024 | 70.75M |
| Date | Value |
|---|---|
| April 12, 2024 | 78.73M |
| April 11, 2024 | 76.54M |
| April 10, 2024 | 77.93M |
| April 09, 2024 | 70.36M |
| April 08, 2024 | 72.55M |
| April 05, 2024 | 63.98M |
| April 04, 2024 | 77.53M |
| April 03, 2024 | 58.80M |
| April 02, 2024 | 58.40M |
| April 01, 2024 | 56.60M |
| March 31, 2024 | 63.98M |
| March 28, 2024 | 60.53M |
| March 27, 2024 | 62.35M |
| March 26, 2024 | 58.49M |
| March 25, 2024 | 43.61M |
| March 22, 2024 | 50.95M |
| March 21, 2024 | 61.00M |
| March 20, 2024 | 61.39M |
| March 19, 2024 | 60.42M |
| March 18, 2024 | 59.45M |
| March 15, 2024 | 52.88M |
| March 14, 2024 | 54.24M |
| March 13, 2024 | 53.08M |
| March 12, 2024 | 54.43M |
| March 11, 2024 | 52.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.102M
Minimum
Dec 21 2022
149.47M
Maximum
Nov 12 2021
45.88M
Average
39.06M
Median
Nov 01 2023
Enterprise Value Benchmarks
| Fortress Biotech Inc | -0.9024M |
| Stereotaxis Inc | 161.38M |
| GT Biopharma Inc | -9.664M |
| Cara Therapeutics Inc | -28.76M |
| FibroGen Inc | 55.95M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.44M |
| Revenue (Quarterly) | 13.03M |
| Total Expenses (Quarterly) | 23.12M |
| EPS Diluted (Quarterly) | -0.53 |
| Gross Profit Margin (Quarterly) | 47.69% |
| Profit Margin (Quarterly) | -80.14% |
| Earnings Yield | -8.99% |
| Operating Earnings Yield | 0.80% |
| Normalized Earnings Yield | -3.701 |